Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Caroli

Showing results (91-100 of 109) with videos related to

Pageof 11
Sort By:
Plos Medicine|April 6, 2019
Octreotide-LAR in later-stage autosomal dominant polycystic kidney disease (ALADIN 2): A randomized, double-blind, placebo-controlled, multicenter trialNorberto Perico, Piero Ruggenenti, Annalisa Perna, et al.
Kidney International Reports|February 12, 2024
An Artificial Intelligence Generated Automated Algorithm to Measure Total Kidney Volume in ADPKDJonathan Taylor, Richard Thomas, Peter Metherall, et al.
Magma (New York, N.Y.)|May 17, 2025
Multi-center and multi-vendor evaluation study across 1.5 T and 3 T scanners (part 2): T1 and T2 standardization in the ISMRM/NIST MR phantomSiria Pasini, Steffen Ringgaard, Tau Vendelboe, et al.
Magma (New York, N.Y.)|May 9, 2025
Multi-center and multi-vendor evaluation study across 1.5 T and 3 T scanners (part 1): apparent diffusion coefficient standardization in a diffusion MRI phantomSiria Pasini, Steffen Ringgaard, Tau Vendelboe, et al.
Neurology|January 9, 2015
Mild cognitive impairment with suspected nonamyloid pathology (SNAP): Prediction of progressionAnna Caroli, Annapaola Prestia, Samantha Galluzzi, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 26, 2016
Effect of Sirolimus on Disease Progression in Patients with Autosomal Dominant Polycystic Kidney Disease and CKD Stages 3b-4Piero Ruggenenti, Giorgio Gentile, Norberto Perico, et al.
Journal of the American Society of Nephrology : JASN|May 15, 2010
Sirolimus therapy to halt the progression of ADPKDNorberto Perico, Luca Antiga, Anna Caroli, et al.
Magma (New York, N.Y.)|October 20, 2019
Technical recommendations for clinical translation of renal MRI: a consensus project of the Cooperation in Science and Technology Action PARENCHIMAIosif Mendichovszky, Pim Pullens, Ilona Dekkers, et al.
Journal of Neurology|July 4, 2019
Prognostic value of Alzheimer's biomarkers in mild cognitive impairment: the effect of age at onsetDaniele Altomare, Clarissa Ferrari, Anna Caroli, et al.
Journal of Alzheimer'S Disease : JAD|October 6, 2011
Disease tracking markers for Alzheimer's disease at the prodromal (MCI) stageValeria Drago, Claudio Babiloni, David Bartrés-Faz, et al.
Pageof 11

Showing results (91-100 of 109) with videos related to

Sort By:
Pageof 11
Plos Medicine|April 6, 2019
Octreotide-LAR in later-stage autosomal dominant polycystic kidney disease (ALADIN 2): A randomized, double-blind, placebo-controlled, multicenter trialNorberto Perico, Piero Ruggenenti, Annalisa Perna, et al.
Kidney International Reports|February 12, 2024
An Artificial Intelligence Generated Automated Algorithm to Measure Total Kidney Volume in ADPKDJonathan Taylor, Richard Thomas, Peter Metherall, et al.
Magma (New York, N.Y.)|May 17, 2025
Multi-center and multi-vendor evaluation study across 1.5 T and 3 T scanners (part 2): T1 and T2 standardization in the ISMRM/NIST MR phantomSiria Pasini, Steffen Ringgaard, Tau Vendelboe, et al.
Magma (New York, N.Y.)|May 9, 2025
Multi-center and multi-vendor evaluation study across 1.5 T and 3 T scanners (part 1): apparent diffusion coefficient standardization in a diffusion MRI phantomSiria Pasini, Steffen Ringgaard, Tau Vendelboe, et al.
Neurology|January 9, 2015
Mild cognitive impairment with suspected nonamyloid pathology (SNAP): Prediction of progressionAnna Caroli, Annapaola Prestia, Samantha Galluzzi, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 26, 2016
Effect of Sirolimus on Disease Progression in Patients with Autosomal Dominant Polycystic Kidney Disease and CKD Stages 3b-4Piero Ruggenenti, Giorgio Gentile, Norberto Perico, et al.
Journal of the American Society of Nephrology : JASN|May 15, 2010
Sirolimus therapy to halt the progression of ADPKDNorberto Perico, Luca Antiga, Anna Caroli, et al.
Magma (New York, N.Y.)|October 20, 2019
Technical recommendations for clinical translation of renal MRI: a consensus project of the Cooperation in Science and Technology Action PARENCHIMAIosif Mendichovszky, Pim Pullens, Ilona Dekkers, et al.
Journal of Neurology|July 4, 2019
Prognostic value of Alzheimer's biomarkers in mild cognitive impairment: the effect of age at onsetDaniele Altomare, Clarissa Ferrari, Anna Caroli, et al.
Journal of Alzheimer'S Disease : JAD|October 6, 2011
Disease tracking markers for Alzheimer's disease at the prodromal (MCI) stageValeria Drago, Claudio Babiloni, David Bartrés-Faz, et al.
Pageof 11